US EditionSingapore Pharma Firms Seek Clarity on US Tariff Exemption, Deputy PM Says
The tariffs target imported patented drugs to boost U.S. manufacturing under Section 232, causing European drugmakers’ shares to fall by up to 3.1%, officials said.
- Starting October 1st, 2025, President Donald Trump announced a 100% tariff on imported branded or patented pharmaceutical products, exempting companies building U.S. manufacturing plants.
- Section 232 of the Trade Expansion Act allows the administration to impose levies without congressional approval after an April U.S. Commerce Department probe into national security risks from drug imports.
- Global pharmaceutical stocks sold off on Friday as markets reacted to the news, with Novo Nordisk A/S falling as much as 15%, GSK Plc dropping 1.1%, and AstraZeneca Plc down 1.6%.
- Exemptions apply only once firms have broken ground on U.S. plants, though major drugmakers including Merck & Co., AstraZeneca and Johnson & Johnson have announced billions in planned U.S. investments.
- EU trade spokesman Olof Gill said the 15% tariff ceiling is an "insurance policy" while Singapore Association of Pharmaceutical Industries and regional officials warned the tariff could harm investments and exports.
51 Articles
51 Articles
Singapore's $3.1 Billion Pharma Industry at Risk From US Tariffs
NEWS BRIEF Singapore’s Deputy Prime Minister Gan Kim Yong said pharmaceutical companies are seeking clarity on potential exemptions from new U.S. tariffs, which threaten $3.1 billion of the city-state’s drug exports. Trade talks are ongoing, with Singapore hoping to secure preferential terms for its pharmaceutical and semiconductor sectors despite a 100% U.S. tariff on branded […] The post Singapore’s $3.1 Billion Pharma Industry at Risk From US…
Singapore pharma firms seek clarity on US tariff exemption, deputy PM says
KUALA LUMPUR (Reuters) -Pharmaceutical companies in Singapore are seeking clarity on whether they would qualify for an exemption from steep tariffs imposed by the United States on their goods, Deputy Prime Minister Gan Kim Yong said on Saturday. Many of the firms have plans to expand or build their business footprint in the United States, which may qualify them for a tariff exemption, Gan, who is also trade minister, told reporters. President Do…
Who's Excited For 100 Percent Tariffs On Pharmaceuticals?!
Photo by Christina Victoria Craft on UnsplashOn Thursday, Donald Trump announced that he would be keeping his campaign promise of lowering pharmaceutical prices by … imposing a 100 percent tariff on all branded and patented pharmaceuticals made overseas unless the companies that manufacture them are breaking ground on US factories in the next less than a week — in which case they will merely be subject to the current 15 percent tariff on most Eu…
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
Watauga Democrat
The nations and firms threatened by Trump's pharma tariffs
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
Coverage Details
Bias Distribution
- 45% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
